Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for novelty
Is consignment a novelty destroying prior use in Australia? Is consignment a novelty destroying prior use in Australia? Reviewed by Dr Claire Gregg on Tuesday, September 01, 2026 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Asude Sena Moya on Tuesday, January 14, 2025 Rating: 5
Bloody good outcome for Impossible Foods as EPO Board of Appeal revives patent for vegan meat substitute (T 0425/23) Bloody good outcome for Impossible Foods as EPO Board of Appeal revives patent for vegan meat substitute (T 0425/23) Reviewed by Jocelyn Bosse on Monday, January 13, 2025 Rating: 5
Plant variety rights for 'Sugraone' grapes invalidated in Italy Plant variety rights for 'Sugraone' grapes invalidated in Italy Reviewed by Jocelyn Bosse on Sunday, August 04, 2024 Rating: 5
To be protected a t-shirt design must be original and/or have individual character, recalls French court To be protected a t-shirt design must be original and/or have individual character, recalls French court Reviewed by Kevin Bercimuelle-Chamot on Tuesday, January 30, 2024 Rating: 5
Never too late: if you missed the IPKat last week Never too late: if you missed the IPKat last week Reviewed by Benjamin Goh on Wednesday, February 01, 2023 Rating: 5
Confidentiality restrictions around clinical trials and prior public use (T 0670/20) Confidentiality restrictions around clinical trials and prior public use (T 0670/20) Reviewed by Dr Rose Hughes on Tuesday, January 31, 2023 Rating: 5
Boards of Appeal back rejection of special criteria for the novelty of purity inventions, but the Guidelines remain out of step (T 0043/18) Boards of Appeal back rejection of special criteria for the novelty of purity inventions, but the Guidelines remain out of step (T 0043/18) Reviewed by Dr Rose Hughes on Tuesday, August 30, 2022 Rating: 5
Hacon HHJ and the Seed Drill: Intentionality in prior use (Claydon v Mzuri, [2021] EWHC 1007) Hacon HHJ and the Seed Drill: Intentionality in prior use (Claydon v Mzuri, [2021] EWHC 1007) Reviewed by Dr Rose Hughes on Tuesday, April 27, 2021 Rating: 5
Untested hypothesis in a clinical trial protocol destroys novelty of a method of treatment claim in Australia (Mylan v Sun Pharma) Untested hypothesis in a clinical trial protocol destroys novelty of a method of treatment claim in Australia (Mylan v Sun Pharma) Reviewed by Dr Rose Hughes on Thursday, August 13, 2020 Rating: 5
An unimpressed LJ Floyd strikes out Regen Lab's UK appeal (Regen v Estar) An unimpressed LJ Floyd strikes out Regen Lab's UK appeal (Regen v Estar) Reviewed by Dr Rose Hughes on Thursday, April 23, 2020 Rating: 5
Taking the measure of the prior art (T 1943/15) Taking the measure of the prior art (T 1943/15) Reviewed by Dr Rose Hughes on Monday, January 20, 2020 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.